| Followers | 1741 |
| Posts | 142040 |
| Boards Moderated | 4 |
| Alias Born | 09/11/2005 |
Thursday, September 18, 2014 7:35:39 AM
re"PXYN.043-This one is worth the time to DD. PRAXSYN-Pharma-Real-Pharmacy-Company-Exponential-REVENUE-Growth...
And yes... will report more than 60 million dollars in revenue THIS QUARTER, and will be PROFITABLE... Will be a lot more than .043 when those numbers are filed with the SEC...
Praxsyn-Pharmaceuticals-This is the next ELTP/TRTC type runner, imo...
I rode ELTP close to the top before selling, sold TRTC way way too early, and we have exactly the same kind of opportunity here, imo, with PXYN... This is a NEW Public company, coming out of a reverse merger...
Chart shows oversold, here, and the mega growth continues... 12 New states selling PXYN just announced...
Praxsyn Corporation
September 4, 2014 3:25 PM
GlobeNewswire
IRVINE, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Praxsyn Corporation (PXYN), today announced that its subsidiary, Mesa Pharmacy Inc., a medication and service provider for medical practitioners, is making progress towards its goal of dispensing its customized medications nationwide. The company is now licensed to dispense its medications in the following twelve states:
• Arizona
• California
• Florida
• Hawaii
• Illinois
• Indiana
• Nevada
• New Mexico
• Oklahoma
• Texas
• Washington
• Wisconsin
Praxsyn is headquartered in Southern California at 18011 Sky Park Circle, Suite N, Irvine, CA 92614, and can be contacted directly at (949) 777-6112.
About Praxsyn
At Praxsyn, we work to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, our wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.
http://finance.yahoo.com/news/praxsyn-now-licensed-dispense-medication-192547337.html
And yes... will report more than 60 million dollars in revenue THIS QUARTER, and will be PROFITABLE... Will be a lot more than .043 when those numbers are filed with the SEC...
Praxsyn-Pharmaceuticals-This is the next ELTP/TRTC type runner, imo...
I rode ELTP close to the top before selling, sold TRTC way way too early, and we have exactly the same kind of opportunity here, imo, with PXYN... This is a NEW Public company, coming out of a reverse merger...
Chart shows oversold, here, and the mega growth continues... 12 New states selling PXYN just announced...
Praxsyn Corporation
September 4, 2014 3:25 PM
GlobeNewswire
IRVINE, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Praxsyn Corporation (PXYN), today announced that its subsidiary, Mesa Pharmacy Inc., a medication and service provider for medical practitioners, is making progress towards its goal of dispensing its customized medications nationwide. The company is now licensed to dispense its medications in the following twelve states:
• Arizona
• California
• Florida
• Hawaii
• Illinois
• Indiana
• Nevada
• New Mexico
• Oklahoma
• Texas
• Washington
• Wisconsin
Praxsyn is headquartered in Southern California at 18011 Sky Park Circle, Suite N, Irvine, CA 92614, and can be contacted directly at (949) 777-6112.
About Praxsyn
At Praxsyn, we work to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, our wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.
http://finance.yahoo.com/news/praxsyn-now-licensed-dispense-medication-192547337.html
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
